Skip to main content

Etiology and Classification of Lymphatic Disorders

  • Chapter
  • First Online:
Lymphedema

Abstract

Beyond lymphedema, in its diverse manifestations, there is a spectrum of human disease that directly or indirectly alters lymphatic structure and function. Diagnosis and differential diagnosis pose distinct challenges. In this overview, various categories of lymphatic disease are enumerated and viewed through the prism of lymphatic embryological development.

  • Defects in the growth and development of lymphatic vessels underlie the lymphatic clinical disorders, including lymphedema, vascular malformations, and lymphangiectasia.

  • Lymphedema represents the most commonly encountered disease state of the lymphatics. It can present in both acquired and heritable forms.

  • Clinical manifestations of primary lymphedema can be mistaken for secondary lymphedema if edema first appears after an apparent provoking secondary inciting event.

  • A genetic predisposition for the development of lymphedema, even when the inciting secondary events are easy to identify.

  • There are at least nine causal mutations known for inherited human lymphedema.

  • Beyond peripheral lymphedema, the spectrum of lymphatic vascular disease is remarkably diverse. The pathological alterations can be isolated, regionalized, or diffuse and can occur in isolation or in concert with other complex vascular lesions.

  • Lymphatic malformations are microcystic, macrocystic, or mixed; generalized lymphatic anomaly is a multifocal lymphatic malformation that can involve the skin, superficial soft tissues, bone, and abdominal and thoracic viscera.

  • In protein-losing enteropathy, loss of lymphatic fluid and plasma protein within the lumen of the gastrointestinal tract can lead to edema and hypoproteinemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Highlighted References

  1. Mortimer PS, Rockson SG. New developments in clinical aspects of lymphatic disease. J Clin Invest. 2014;124(3):915–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Connell FC, Gordon K, Brice G, Keeley V, Jeffery S, Mortimer PS, et al. The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings. Clin Genet. 2013;84(4):303–14.

    Article  CAS  PubMed  Google Scholar 

  3. Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, et al. Vascular anomalies classification: recommendations from the International Society for the Study of vascular anomalies. Pediatrics. 2015;136(1):e203–14.

    Article  PubMed  Google Scholar 

  4. Radhakrishnan K, Rockson SG. The clinical spectrum of lymphatic disease. Ann N Y Acad Sci. 2008;1131:155–84.

    Article  PubMed  Google Scholar 

References

  1. Secker GA, Harvey NL. VEGFR signaling during lymphatic vascular development: from progenitor cells to functional vessels. Dev Dyn. 2015;244(3):323–31.

    Article  CAS  PubMed  Google Scholar 

  2. Wigle JT, Harvey N, Detmar M, Lagutina I, Grosveld G, Gunn MD, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 2002;21(7):1505–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kazenwadel J, Harvey NL. Morphogenesis of the lymphatic vasculature: a focus on new progenitors and cellular mechanisms important for constructing lymphatic vessels. Dev Dyn. 2016;245(3):209–19.

    Article  PubMed  Google Scholar 

  4. Rockson SG. Lymphedema. Am J Med. 2001;110(4):288–95.

    Article  CAS  PubMed  Google Scholar 

  5. Rockson SG. Diagnosis and management of lymphatic vascular disease. J Am Coll Cardiol. 2008;52(10):799–806.

    Article  PubMed  Google Scholar 

  6. Nakamura K, Rockson SG. Molecular targets for therapeutic lymphangiogenesis in lymphatic dysfunction and disease. Lymphat Res Biol. 2008;6(3–4):181–9.

    Article  PubMed  Google Scholar 

  7. Greene AK, Grant FD, Maclellan RA. Obesity-induced lymphedema nonreversible following massive weight loss. Plast Reconstr Surg Glob Open. 2015;3(6):e426.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Greene AK, Grant FD, Slavin SA, Maclellan RA. Obesity-induced lymphedema: clinical and lymphoscintigraphic features. Plast Reconstr Surg. 2015;135(6):1715–9.

    Article  CAS  PubMed  Google Scholar 

  9. Rockson SG. The unique biology of lymphatic edema. Lymphat Res Biol. 2009;7(2):97–100.

    Article  PubMed  Google Scholar 

  10. Miaskowski C, Dodd M, Paul SM, West C, Hamolsky D, Abrams G, et al. Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery. PLoS One. 2013;8(4):e60164.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Nonne M. Vier Fälle von elephantiasis congenita hereditaria. Virchows Arch. 1891;125:189–96.

    Article  Google Scholar 

  12. Milroy W. An undescribed variety of hereditary oedema. NY Med J. 1892;56:505–8.

    Google Scholar 

  13. Brice G, Child AH, Evans A, Bell R, Mansour S, Burnand K, et al. Milroy disease and the VEGFR-3 mutation phenotype. J Med Genet. 2005;42(2):98–102.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Falls HF, Kertesz ED. A new syndrome combining pterygium colli with developmental anomalies of the eyelids and lymphatics of the lower extremities. Trans Am Ophthalmol Soc. 1964;62:248–75.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Faul JL, Berry GJ, Colby TV, Ruoss SJ, Walter MB, Rosen GD, et al. Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med. 2000;161(3 Pt 1):1037–46.

    Article  CAS  PubMed  Google Scholar 

  16. Connell FC, Kalidas K, Ostergaard P, Brice G, Murday V, Mortimer PS, et al. CCBE1 mutations can cause a mild, atypical form of generalized lymphatic dysplasia but are not a common cause of non-immune hydrops fetalis. Clin Genet. 2012;81(2):191–7.

    Article  CAS  PubMed  Google Scholar 

  17. Fotiou E, Martin-Almedina S, Simpson MA, Lin S, Gordon K, Brice G, et al. Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis. Nat Commun. 2015;6:8085.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Chiu NT, Lee BF, Hwang SJ, Chang JM, Liu GC, Yu HS. Protein-losing enteropathy: diagnosis with (99m)Tc-labeled human serum albumin scintigraphy. Radiology. 2001;219(1):86–90.

    Article  CAS  PubMed  Google Scholar 

  19. Hilliard RI, McKendry JB, Phillips MJ. Congenital abnormalities of the lymphatic system: a new clinical classification. Pediatrics. 1990;86(6):988–94.

    CAS  PubMed  Google Scholar 

  20. Freeman HJ, Nimmo M. Intestinal lymphangiectasia in adults. World J Gastrointest Oncol. 2011;3(2):19–23.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Fox U, Lucani G. Disorders of the intestinal mesenteric lymphatic system. Lymphology. 1993;26(2):61–6.

    CAS  PubMed  Google Scholar 

  22. Jermann M, Eid K, Pfammatter T, Stahel R. Maffucci‘s syndrome. Circulation. 2001;104(14):1693.

    Article  CAS  PubMed  Google Scholar 

  23. Prokopchuk O, Andres S, Becker K, Holzapfel K, Hartmann D, Friess H. Maffucci syndrome and neoplasms: a case report and review of the literature. BMC Res Notes. 2016;9:126.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Patel DV. Gorham's disease or massive osteolysis. Clin Med Res. 2005;3(2):65–74.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Ozeki M, Fujino A, Matsuoka K, Nosaka S, Kuroda T, Fukao T. Clinical features and prognosis of generalized lymphatic anomaly, kaposiform lymphangiomatosis, and gorham-stout disease. Pediatr Blood Cancer. 2016;63(5):832–8.

    Article  PubMed  Google Scholar 

  26. Kihiczak GG, Meine JG, Schwartz RA, Janniger CK. Klippel-Trenaunay syndrome: a multisystem disorder possibly resulting from a pathogenic gene for vascular and tissue overgrowth. Int J Dermatol. 2006;45(8):883–90.

    Article  PubMed  Google Scholar 

  27. Revencu N, Boon LM, Dompmartin A, Rieu P, Busch WL, Dubois J, et al. Germline mutations in RASA1 are not found in patients with klippel-trenaunay syndrome or capillary malformation with limb overgrowth. Mol Syndromol. 2013;4(4):173–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Okhovat JP, Alavi A. Lipedema: a review of the literature. Int J Low Extrem Wounds. 2015;14(3):262–7.

    Article  PubMed  Google Scholar 

  29. Warren AG, Janz BA, Borud LJ, Slavin SA. Evaluation and management of the fat leg syndrome. Plast Reconstr Surg. 2007;119(1):9e–15e.

    Article  PubMed  Google Scholar 

  30. Glasgow CG, Taveira-DaSilva A, Pacheco-Rodriguez G, Steagall WK, Tsukada K, Cai X, et al. Involvement of lymphatics in lymphangioleiomyomatosis. Lymphat Res Biol. 2009;7(4):221–8.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Moir LM. Lymphangioleiomyomatosis: current understanding and potential treatments. Pharmacol Ther. 2016;158:114–24.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stanley G. Rockson .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Rockson, S.G. (2018). Etiology and Classification of Lymphatic Disorders. In: Lee, BB., Rockson, S., Bergan, J. (eds) Lymphedema. Springer, Cham. https://doi.org/10.1007/978-3-319-52423-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52423-8_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52421-4

  • Online ISBN: 978-3-319-52423-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics